Pregnenolone Carbonitrile
CAS No. 1434-54-4
Pregnenolone Carbonitrile( 5-Pregnen-3β-ol-20-one-16α-carbonitrile | Pregnenolone 16α-carbonitrile? )
Catalog No. M27472 CAS No. 1434-54-4
Pregnenolone Carbonitrile is an activator of rodent-PXR and induces the expression of CYP3A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 35 | Get Quote |
|
| 5MG | 58 | Get Quote |
|
| 10MG | 87 | Get Quote |
|
| 25MG | 152 | Get Quote |
|
| 50MG | 224 | Get Quote |
|
| 100MG | 336 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePregnenolone Carbonitrile
-
NoteResearch use only, not for human use.
-
Brief DescriptionPregnenolone Carbonitrile is an activator of rodent-PXR and induces the expression of CYP3A.
-
DescriptionPregnenolone Carbonitrile is an activator of rodent-PXR and induces the expression of CYP3A.(In Vitro):Pregnenolone Carbonitrile is hepatoprotective by increasing resistance to subsequent stressful insults.(In Vivo):In WT mice, Pregnenolone Carbonitrile (40 mg/kg/day; i.p.) induces the expression of CYP3A11 and CYP2B10 at the mRNA, protein, and enzymatic levels. In adult female Sprague-Dawley rats, Pregnenolone Carbonitrile (100 mg/kg; i.p.) induces the expression of CYP3A mRNA. In male Sprague-Dawley rats, Pregnenolone Carbonitrile (35 mg/kg; gavage) increase in Pgp expression.
-
In Vitro——
-
In VivoAnimal Model:WT and Pxr-/- mice Dosage:40 mg/kg Administration:IP; per day for two days Result:Induced the expression of Cyp3a11 and Cyp2b10 at the mRNA, protein, and enzymatic levels in WT mice.Had little effect on the expression of Cyp3a11 in Pxr-/- mice
-
Synonyms5-Pregnen-3β-ol-20-one-16α-carbonitrile | Pregnenolone 16α-carbonitrile?
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
Recptorenoyl-acyl carrier protein reductase (FabI)|S. aureus
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1434-54-4
-
Formula Weight341.49
-
Molecular FormulaC22H31NO2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 20 mg/mL (58.57 mM)
-
SMILESC[C@@]12[C@]([C@]3([C@](CC1)([C@]4(C)C(=CC3)C[C@@H](O)CC4)[H])[H])(C[C@@H](C#N)[C@@H]2C(C)=O)[H]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kim BY, Sohn YT. Solid state of CG-400549, a novel FabI inhibitor: characterization, dissolution, transformation. Arch Pharm Res. 2011 May;34(5):775-9.
molnova catalog
related products
-
Mephenytoin
Mephenytoin is an anticonvulsant and a substrate of CYP2C19 and CYP2B6.
-
Liarozole
Liarozole is a cytochrome P450 (CYP450) dependent inhibitor, orally active, it also a potent inhibitor of estrogen (via inhibition of aromatase) and testicular androgen synthesis (inhibition of 17 ,20-lyase).
-
Anemosapogenin
Anemosapogenin shows potent anti-tumor effect in vivo, but it has some toxicity, structure modification should be needed.
Cart
sales@molnova.com